OQROGet OQRO Pro
Insider trade

GE HealthCare (GEHC)Director bought ~$642K

Kevin Lobo, Director at GE HealthCare, bought ~$642K of GE HealthCare shares.

~$642K
Approx. value · 10K sh @ $64.18
14K
Holds after · shares reported
Traded
May 22, 2026
Filed
May 26, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 23, 2026CongressDisclosed sale of GEHC — reported range $1,001 - $15,000
  2. Mar 25, 2026CongressDisclosed sale of GEHC — reported range $1,001 - $15,000
  3. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  4. Mar 27, 2026CongressDisclosed purchase of GEHC — reported range $1,001 - $15,000
  5. Apr 29, 2026Company filing · Form 8-K · ResultsReported its results
  6. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.3%
  7. Apr 30, 2026Insider · 2 peopleInsiders: 2 purchases (~$356K)
  8. May 1, 2026Insider · 3 insiders in a week, a first since 2023CFO purchased ~$201K of GEHC shares in the open market
  9. May 6, 2026Insider · 2 peopleInsiders: 2 purchases (~$5.1M)
  10. May 8, 2026Insider · 3 insiders in a week, 2nd time since 2023Director purchased ~$63K of GEHC shares in the open market
  11. May 12, 2026Insider · 4 insiders in a week, a first since 2023Director purchased ~$100K of GEHC shares in the open market
  12. May 14, 20265% stakeCapital Research Global Investors reported a passive stake (13G) of 4.6%
  13. May 14, 20265% stakeDodge & Cox reported a passive stake (13G) of 6.9%
  14. May 22, 2026 · this disclosureInsider · Their first buy on recordDirector purchased ~$642K of GEHC shares in the open market

What came next

  1. Jul 21, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“On July 21, 2026, James K. (Jay) Saccaro notified GE HealthCare that he will resign as Chief Financial Officer for a role outside of the medical technology industry.”
  2. Jul 24, 2026FDAFDA device clearance: Monitor B105M; Monitor B125M; Monitor B155M; Monitor B105P; Monitor B125P
  3. Jul 29, 2026Company filing · Form 8-K · ResultsReported its results
  4. Jul 30, 2026FDAFDA device clearance: LOGIQ Focus
  5. Jul 30, 2026FDARecall: Carescape Central Station CSCS V3 MAS800 Desktop Part Number 5867474-04, 5867474-13 Product code STU CSCS V3 MAI800 Integrated Part Number 5867474-03 Product C…
  6. Jul 31, 2026FDARecall: Centricity PACS Server V7, intended for managing digital medical images and associated data, All versions
  7. Jul 31, 2026FDARecall: Centricity PACS V2, V3, V4, V6, V7, software product is intended for the storage, reading, diagnostic review, analysis, annotation, distribution, printing, edi…
  8. Jul 31, 2026FDARecall: Centricity Enterprise Archive V2, V3, and V4, software product for receiving, archiving, and sending electronic medical data, All Versions
  9. Jul 31, 2026FDARecall: Core Services Hub V8, a set of backend services including Cross Enterprise (XE) and Workflow Core (WFC) services that enables enterprise imaging workflows, All…
  10. Jul 31, 2026FDARecall: Workflow Core Services V8, intended to provide set of services for storage and retrieval of patient data, exams and performs system Administration, common conf…
  11. Jul 31, 2026FDARecall: Enterprise Archive V8, software product for receiving, archiving, and sending electronic medical data, All versions
  12. Aug 7, 2026FDAFDA device clearance: Venue Go
  13. Aug 7, 20265% stakeDodge & Cox reported a passive stake (13G) of 8.3%
  14. Aug 7, 20265% stakeDodge & Cox reported a passive stake (13G) of 10.5%
  15. Aug 13, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 13, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (“GE HealthCare”) appointed William K. Grogan as Chief Financial Officer, effective September 14, 2026.”
  16. Aug 13, 2026FDAFDA device clearance: AIR Recon DL
  17. Aug 28, 2026FDAFDA device clearance: Carescape Canvas 1000; Carescape Canvas Smart Display
  18. Sep 1, 2026FDAFDA device clearance: Carescape ONE; Carescape Dock F0; TruSignal ECG MM; TruSignal PRES MM; TruSignal TEMP MM; TruSignal SpO2 MM 1.8M; TruSignal SpO2 MM 3.0M
  19. Sep 2, 2026FDAFDA device clearance: Vivid Explorer/Vivid Advanced/Vivid Focus
  20. Sep 16, 2026FDAFDA device clearance: EchoPAC Software Only / EchoPAC Plug-in (v211)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for GE HealthCare

For GE HealthCare, OQRO holds 1 Congress trade report and 25 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GEHC page.

Other recent filings by Kevin Lobo, Director

The full history of Kevin Lobo, Director is on the profile page.

How this filing works

Other disclosures at GE HealthCare

Everything OQRO holds on this company is on its GEHC page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data